Answers are grounded in this paper and cite their sources.
NF-kappaB inhibition may represent a potent treatment modality in colorectal cancer, especially in cases with constitutive NF-kappaB activation.
No takes yet. Share an insight, caveat, or question.
Sakamoto et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: